ARTICLE | Clinical News
MRVT starts Phase II psoriasis study
January 8, 2002 8:00 AM UTC
Miravant Medical (MRVT) began a U.S. open-label, dose-ranging Phase II trial of its PhotoPoint photodynamic therapy (PDT) in 54 patients with moderate plaque psoriasis. Patients will receive varying d...